Male Contraceptive Halts Development Of Sperm
Featured ArticleMain Category: Urology / Nephrology
Also Included In: Men's health; Fertility; Sexual Health / STDs
Article Date: 30 Oct 2006 - 9:00 PDT
email to a friend 
printer friendly 
opinions
| Patient / Public: |  |
4.5 (38 votes) |
| Healthcare Prof: |  |
3.8 (15 votes) |
Tests on rats have shown that an experimental male contraceptive drug blocks connections to cells which feed the developing sperm - making the male infertile, say American and Italian scientists. As fairly low doses of the drug are needed, no significant side-effects were detected.
The scientists said the infertility is not permanent, as soon as treatment stops the male is soon fertile again. They added that further studies are needed to find out whether the drug is as effective and safe with human males.
You can read about this research in the journal Nature Medicine.
In order for sperm to grow and become mature, they need to be located next to Sertoli cells. Sertoli cells nurse the sperm and aid their development. The scientists wanted to see whether it was possible to break the connection between the sperm and the Sertoli cells.
In order to disconnect the two (sperm and Sertoli cells), the researchers used Adjudin, a new molecule. However, Adjudin is toxic if too much is applied. To keep the dosage low, Adjudin was linked to inactive FSH, a hormone. The inactive FSH carried the low-dose Adjudin directly to the area where it could effectively block communication between the sperm and Sertoli cells. This resulted in the male rats not being able to reproduce.
Team leader, Dr. D Mruk, the Center For Biomedical Research, New York, believes they have found a drug which could eventually become a male contraceptive pill.
"A male contraceptive targeting germ cell adhesion"
Dolores D Mruk, Ching-Hang Wong, Bruno Silvestrini & C Yan Cheng
Nature Medicine Published online: 29 October 2006; doi:10.1038/nm1420
Click here to see abstract online
Written by: Christian Nordqvist
Editor: Medical News Today
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/articles/55367.php>
APA
http://www.medicalnewstoday.com/articles/55367.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Privacy Policy |
Terms and Conditions
MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
